Sergio Siragusa. (2011). Low molecular weight heparins in cancer patients: To treat thromboembolic events, the tumor, or both? Frontiers Media S.A..
Chicago Style (17th ed.) CitationSergio Siragusa. Low Molecular Weight Heparins in Cancer Patients: To Treat Thromboembolic Events, the Tumor, or Both? Frontiers Media S.A., 2011.
MLA (9th ed.) CitationSergio Siragusa. Low Molecular Weight Heparins in Cancer Patients: To Treat Thromboembolic Events, the Tumor, or Both? Frontiers Media S.A., 2011.
Warning: These citations may not always be 100% accurate.